LS

Lalitha Siva Jyothi Eepuru

Active Director Designated Partner DIN 07552278
DIN 07552278 First appointment May 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Lalitha Siva Jyothi Eepuru

Data last updated:

Lalitha Siva Jyothi Eepuru is a Designated Partner at Dr. Raja Sekhar Eye Hospital Llp (since 2022). The company operates in Healthcare.

DIN 07552278
Primary Designation Designated Partner
Industry Healthcare
First Appointment 30 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 May 20222022Active

Board colleagues of Lalitha Siva Jyothi Eepuru

NameDINCompanyDesignation
Pabolu Raja Sekhar07542589Dr. Raja Sekhar Eye Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Dr. Raja Sekhar Eye Hospital Llp
Premium access

Shareholding and investment profile for Lalitha Siva Jyothi Eepuru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lalitha Siva Jyothi Eepuru

Lalitha Siva Jyothi Eepuru currently holds 1 directorship: Dr. Raja Sekhar Eye Hospital Llp (Designated Partner, since 30 May 2022).

Lalitha Siva Jyothi Eepuru was first appointed on 30 May 2022 as Designated Partner at Dr. Raja Sekhar Eye Hospital Llp.

The current boards of Lalitha Siva Jyothi Eepuru's companies include Pabolu Raja Sekhar (Dr. Raja Sekhar Eye Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available